• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
XU Hongjiang, SHI Wei, SONG Wei, ZHANG Ying, ZHAO Kaidi, ZHANG Yinsheng, YANG Ling, WANG Jinan. Pharmacodynamic study of magnesium isoglycyrrhizinate in HBV transgenic mouse model[J]. Journal of China Pharmaceutical University, 2019, 50(4): 475-480. DOI: 10.11665/j.issn.1000-5048.20190413
Citation: XU Hongjiang, SHI Wei, SONG Wei, ZHANG Ying, ZHAO Kaidi, ZHANG Yinsheng, YANG Ling, WANG Jinan. Pharmacodynamic study of magnesium isoglycyrrhizinate in HBV transgenic mouse model[J]. Journal of China Pharmaceutical University, 2019, 50(4): 475-480. DOI: 10.11665/j.issn.1000-5048.20190413
shu

Pharmacodynamic study of magnesium isoglycyrrhizinate in HBV transgenic mouse model

More Information
    Graphical Abstract
    • Abstract
  • This study aims to discuss the therapeutic effect of magnesium isoglycyrrhizinate on hepatitis B virus(HBV)transgenic mouse and its effect on cellular immunity and liver inflammation. The changes of serum aspartate aminotransferase(AST)and alanine aminotransferase(ALT)activity, the difference of serum hepatitis B surface antigen(HBsAg), liver tissue HBsAg mRNA, and the pathological morphological changes of liver tissue were detected to investigate the hepatic inflammatory lesions and the efficacy of magnesium isoglycyrrhizinate in HBV transgenic mouse. Peripheral blood lymphocytes were classified by flow cytometry, and serum cytokines were detected by cytometric bead array(CBA)to explore the mechanism of magnesium isoglycyrrhizinate to reduce hepatic inflammatory lesions in HBV transgenic mouse. After grouping HBV transgenic mouse with serum transaminase activity and 35 days of continuous administration, serum transaminases level in magnesium isoglycyrrhizinate ［15 mg/(kg ·d)］ group was significantly lower than that in control group(P< 0. 05), serum HBsAg protein and liver tissue HBsAg mRNA increased with time, but there was no significant difference between the two groups. The main pathological changes of liver were liver cell swelling, necrosis and focal inflammatory cell infiltration, and the pathological changes of liver in magnesium isoglycyrrhizinate group were lighter than those in control group. The number of CD8+ cells in the blood of magnesium isoglycyrrhizinate group was significantly less than that in the control group(P< 0. 05)and the CD4+/CD8+ cell ratio was significantly higher than that in the control group(P< 0. 05). The content of inflammatory cytokines in serum of magnesium isoglycyrrhizinate group decreased significantly(P< 0. 05). Magnesium isoglycyrrhizinate can regulate the immune function of HBV transgenic mouse, decrease the infiltration of inflammatory cells in hepatic tissue and hepatocyte injury, but do not affect the expression of hepatocyte HBsAg.
    • FullText(HTML)
    • References (14)
  • [1]
    Xie C,Li X,Zhu J,et al.Magnesium isoglycyrrhizinate suppresses LPS-induced inflammation and oxidative stress through inhibiting NF-κB and MAPK pathways in RAW264.7 cells[J].Bioorg Med Chem,2019,27(3):516-524.
    [2]
    Ma D,Zhang J,Zhang Y,et al.Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-κB signaling pathway in mice[J].Int Immunopharmacol,2018,55:237-244.
    [3]
    Ou MH.Pharmacology and clinical research progress of magnesium isoglycyrrhizinate[J].China Pharm(中国药业),2010,19(15):83-85.
    [4]
    Guo WN,Zhu B,Ai L,et al.Animal models for the study of hepatitis B virus infection[J].Zool Res,2018,39(1):25-31.
    [5]
    Dupinay T,Gheit T,Roques P,et al.Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from Mauritius Island[J].Hepatol,2013,58(5):1610-1620.
    [6]
    Dandri M,Volz TK,Lütgehetmann M,et al.Animal models for the study of HBV replication and its variants[J].J Clin Virol,2005,34(Suppl 1):S54-S62.
    [7]
    Chisari FV,Pinkert CA,Milich DR,et al.A transgenic mouse model of the chronic hepatitis B surface antigen carrier state[J].Science,1985,230(4730):1157-1160.
    [8]
    Babinet C,Farza H,Morello D,et al.Specific expression of hepatitis B surface antigen(HBsAg)in transgenic mouse[J].Science,1985,230(4730):1160-1163.
    [9]
    Guidotti L G,Matzke B,Schaller H,et al.High-level hepatitis B virus replication in transgenic mouse[J].J Virol,1995,69(10):6158-6169.
    [10]
    Kang AJ,Dong YH,Tian F,et al.Pathologic observation on C57BL/6J-HBV transgenic mouse[J].Chin J Lab Anim Sci(中国实验动物学杂志),2002,12(1):8-10.
    [11]
    Huang LR,Wu HL,Chen PJ,et al.An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection[J].Proc Natl Acad Sci,2006,103(47):17862-17867.
    [12]
    Huang YH,Fang CC,Tsuneyama K,et al.A murine model of hepatitis B-associated hepatocellular carcinoma generated by adeno-associated virus-mediated gene delivery[J].Int J Oncol,2011,39(6):1511-1519.
    [13]
    Dembek C,Protzer U.Mouse models for therapeutic vaccination against hepatitis B virus[J].Med Microbiol Immunol,2015,204(1):95-102.
    [14]
    Zheng DM,Guo YH,Zheng F.Flow cytometry analysis of intrahepatic lymphocyte subsets in chronic hepatitis B[J].J Mod Med Health(现代医药卫生),2012,28(1):102-104.
    • Related Articles

  • Related Articles

    [1]SHI Min, YONG Qin, HE Yingna, HUANG Shiqin, ZHAO Xuan, YU Xian. Construction and in vivo evaluation of a thermosensitive hydrogel system loading with Pseudomonas aeruginosa DNA vaccine[J]. Journal of China Pharmaceutical University, 2021, 52(2): 186-194. DOI: 10.11665/j.issn.1000-5048.20210207
    [2]CHEN Ye, YIN Jun, YAO Wenbing, GAO Xiangdong. Advances of DNA-based nanomaterials in tumor therapy[J]. Journal of China Pharmaceutical University, 2020, 51(4): 406-417. DOI: 10.11665/j.issn.1000-5048.20200404
    [3]WANG Rui, WANG Yongmei, CAI Mingjun, KE Xuejia, WU Yue, CHONG Jun, CAO Rongyue. Pharmacological effects of anti-melanoma DC vaccine sensitized by fusion proteins of G3G6 and HST1[J]. Journal of China Pharmaceutical University, 2019, 50(2): 238-245. DOI: 10.11665/j.issn.1000-5048.20190216
    [4]HAN Xiu, QI Xiaole, WU Zhenghong. Advances in self-assemblied DNA nanocages as drug delivery systems[J]. Journal of China Pharmaceutical University, 2017, 48(6): 663-669. DOI: 10.11665/j.issn.1000-5048.20170605
    [5]ZHANG Zhiqing, WANG Fang, ZHOU Ting, ZHANG Guodong, WANG Xiufeng, LI Yunze. A DNA polyaptamer system as a targeted antitumor drug delivery[J]. Journal of China Pharmaceutical University, 2015, 46(4). DOI: 10.11665/j.issn.1000-5048.20150408
    [6]Formula optimization and transfection efficiency of polyethyleneimine/DNA complexes[J]. Journal of China Pharmaceutical University, 2010, 41(1): 40-44.
    [7]Study on the Flavonoids from Lonicera confusa DC.[J]. Journal of China Pharmaceutical University, 2004, (4): 9-12.
    [8]Applications of Au Nanoparticles Labeling Method in DNA-detection and the Technology of Genechip[J]. Journal of China Pharmaceutical University, 2003, (2): 88-93.
    [9]The Isoquinolones from Menispermum dauricum DC.[J]. Journal of China Pharmaceutical University, 2001, (2): 16-17.
    [10]Ptotoplast Transformation of Staphylococcal DNA[J]. Journal of China Pharmaceutical University, 1992, (4): 239-242.

  • Cited by

    Periodical cited type(3)

    1. 石敏，雍琴，何颖娜，黄仕琴，赵轩，余娴. 载铜绿假单胞菌DNA疫苗温敏水凝胶系统的构建及体内评价. 中国药科大学学报. 2021(02): 186-194 . 本站查看
    2. 雍琴，岳瀚勋，石敏，黄仕琴，赵轩，余娴. pH响应性PTEN/PLGA-(HE)_(10)-MAP纳米粒的构建及体外评价. 中国药科大学学报. 2021(03): 301-310 . 本站查看
    3. 冯旸，徐霄，莫然. 淋巴靶向药物递送系统在抗肿瘤转移治疗中的研究进展. 中国药科大学学报. 2020(04): 425-432 . 本站查看

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML
    Article views (518) PDF downloads (772) Cited by(5)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：323990

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return